212 related articles for article (PubMed ID: 35883579)
1. Gremlin-1 Promotes Colorectal Cancer Cell Metastasis by Activating ATF6 and Inhibiting ATF4 Pathways.
Li R; Zhou H; Li M; Mai Q; Fu Z; Jiang Y; Li C; Gao Y; Fan Y; Wu K; Costa CD; Sheng X; He Y; Li N
Cells; 2022 Jul; 11(14):. PubMed ID: 35883579
[TBL] [Abstract][Full Text] [Related]
2. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
4. DHA inhibits Gremlin-1-induced epithelial-to-mesenchymal transition via ERK suppression in human breast cancer cells.
Sung NJ; Kim NH; Bae NY; Jo HS; Park SA
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141512
[TBL] [Abstract][Full Text] [Related]
5. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
6. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
Liu Y; Li Y; Hou R; Shu Z
J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
[TBL] [Abstract][Full Text] [Related]
7. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression.
Karagiannis GS; Musrap N; Saraon P; Treacy A; Schaeffer DF; Kirsch R; Riddell RH; Diamandis EP
Biol Chem; 2015 Feb; 396(2):163-83. PubMed ID: 25153376
[TBL] [Abstract][Full Text] [Related]
9. Gremlin-1 Promotes Metastasis of Breast Cancer Cells by Activating STAT3-MMP13 Signaling Pathway.
Sung NJ; Kim NH; Surh YJ; Park SA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287358
[TBL] [Abstract][Full Text] [Related]
10. Gremlin1 promotes carcinogenesis of glioma in vitro.
Guan Y; Cheng W; Zou C; Wang T; Cao Z
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):244-256. PubMed ID: 27862197
[TBL] [Abstract][Full Text] [Related]
11. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
12. PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407.
Tan X; Chen S; Wu J; Lin J; Pan C; Ying X; Pan Z; Qiu L; Liu R; Geng R; Huang W
Cell Death Dis; 2017 Mar; 8(3):e2686. PubMed ID: 28300833
[TBL] [Abstract][Full Text] [Related]
13. CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.
Zhao GX; Xu YY; Weng SQ; Zhang S; Chen Y; Shen XZ; Dong L; Chen S
Oncogene; 2019 Jun; 38(23):4574-4589. PubMed ID: 30742066
[TBL] [Abstract][Full Text] [Related]
14. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.
Yang C; Dou R; Wei C; Liu K; Shi D; Zhang C; Liu Q; Wang S; Xiong B
Mol Ther; 2021 Jun; 29(6):2088-2107. PubMed ID: 33571679
[TBL] [Abstract][Full Text] [Related]
16. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.
Liu W; Wang S; Sun Q; Yang Z; Liu M; Tang H
Int J Cancer; 2018 May; 142(10):2068-2079. PubMed ID: 29277893
[TBL] [Abstract][Full Text] [Related]
17. Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1.
Jiang X; Li D; Wang G; Liu J; Su X; Yu W; Wang Y; Zhai C; Liu Y; Zhao Z
Oncol Rep; 2020 Apr; 43(4):1245-1255. PubMed ID: 32323831
[TBL] [Abstract][Full Text] [Related]
18. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways.
Chen B; Zeng X; He Y; Wang X; Liang Z; Liu J; Zhang P; Zhu H; Xu N; Liang S
Oncotarget; 2016 Nov; 7(44):71400-71416. PubMed ID: 27662663
[TBL] [Abstract][Full Text] [Related]
19. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1.
Karagiannis GS; Berk A; Dimitromanolakis A; Diamandis EP
Mol Oncol; 2013 Aug; 7(4):826-39. PubMed ID: 23659962
[TBL] [Abstract][Full Text] [Related]
20. ATF6 pathway of unfolded protein response mediates advanced oxidation protein product-induced hypertrophy and epithelial-to-mesenchymal transition in HK-2 cells.
Tang X; Liang X; Li M; Guo T; Duan N; Wang Y; Rong G; Yang L; Zhang S; Zhang J
Mol Cell Biochem; 2015 Sep; 407(1-2):197-207. PubMed ID: 26045172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
